RAPT (rapt.com) Sof foyda

RAPT (RAPT Therapeutics) - kompaniyaning tovar belgisi

Geopolitik keskinliklar va sanksiyalar global sinovlarni o'tkazish hamda biomateriallarning harakatlanishiga jiddiy to'sqinlik qilmoqda, bu esa yangi immun terapiyalarining chiqarilishini sekinlashtirmoqda. Shu bilan birga, RAPT Therapeutics, Inc. (RAPT) saraton va yallig'lanishga qarshi kurashish uchun kichik molekulalarni faol ravishda ishlab chiqmoqda va o'rta bosqichli tadqiqotlar davomida ma'lumotlar to'plamoqda. Quyidagi narxlar grafigi foyda dinamikasini aks ettiradi, u hozirda -0.11 darajasida bo'lib, kompaniyaning innovatsion terapiyalar ishlab chiquvchisi sifatidagi maqomini tasdiqlaydi.

RAPT (RAPT Therapeutics) Sof foyda tarixi 04.07.2022dan 14.03.2026gacha

RAPT Therapeutics (RAPT) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari rapt.com|RAPT - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi RAPT Therapeutics, Inc.|RAPT - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati RAPT Therapeutics|RAPT - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi rapt.com|RAPT - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati RAPT Therapeutics, Inc.|RAPT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati RAPT Therapeutics Inc.|RAPT - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar RAPT Therapeutics, Inc.|RAPT - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi RAPT Therapeutics|Shoshilinch likvidlik rapt.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
RAPT - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:RAPT Therapeutics, Inc.
RAPT Therapeutics, Inc. asosiy tovari

Uzoq muddatli aktivlarni saralash risklarni minimallashtirish uchun kassa oqimlarining aniq monitoringini talab qiladi. Ushbu ko'rsatkich standart choraklik kechikishlarni bartaraf etgan holda, sof foydaning kapital qiymatini har kuni uzluksiz ravishda o'lchaydi. RAPT Therapeutics, Inc. (RAPT) uchun bunday detallashgan yondashuv R&D xarajatlarini baholash va tartibga soluvchi to'siqlarni yengib o'tishda juda muhimdir. Immuno-onkologik ishlanmalarning samaradorligi kompaniya tomonidan yaratilgan daromadga bevosita ta'sir qiladi. Aktivlarning haddan tashqari qiziganini aniqlash uchun ushbu grafik dinamikasini tahlil qiling.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|PGEN - Kompaniyaning sof foydasi|Yakuniy foyda PHAR (Pharming Corp)|NKTR: Sof foyda|upstreambio.com (UPB) - Sof foyda|Kompaniyaning sof foydasi Zenas Biopharma|Immunome Inc - Soliqdan keyingi foyda|Sof daromad GOSS (Gossamer Corp)|Soliqlar to‘langandan keyingi foyda KALV|Septerna Inc - Sof daromad|Yakuniy foyda PVLA|SVRA: Sof daromad|Rigel Pharma - Soliqlar to‘langandan keyingi foyda|ANAB: Sof foyda|Astria Corp - Yakuniy foyda|ENGN (enGene Holdings Inc.) - Sof foyda|Kompaniyaning sof daromadi Aerovate JBIO|Kompaniyaning sof foydasi Aclaris Therapeutics, Inc. (ACRS)|KYTX (Kyverna Therapeutics Inc.) - Yakuniy foyda|Sof foyda TLSA (Tiziana Life Sciences PLC)|Sof foyda Cabaletta Bio Inc CABA|VTYX - Kompaniyaning sof foydasi|Soliqdan keyingi foyda THTX|AVTX: Sof foyda|Kompaniyaning sof daromadi Eledon Pharmaceuticals Inc. (ELDN)|Sof daromad AGEN|Sof foyda Climb Bio, Inc|Sof daromad ZURA (Zura Bio Limited)|Soliqlar to‘langandan keyingi foyda ATYR|Sof foyda ADAG (Adagene Inc.)|Sof moliyaviy natija ImageneBio (IMA)|Shattuck Therapeutics - Sof foyda|Equillium, Inc. (EQ) - Sof daromad|connectbiopharm.com (CNTB) - Kompaniyaning sof foydasi|IMUX - Sof moliyaviy natija|Sof daromad ATRA|IFRX: Yakuniy foyda|Sof foyda XFOR|Sof moliyaviy natija adicetbio.com|Kompaniyaning sof foydasi Celularity CELU|INMB: Kompaniya foydasi|Barinthus Biotherapeutics plc - Sof foyda|Kezar Life Sciences Inc. (KZR) - Sof daromad|SABS (SAB Biotherapeutics, Inc) - Sof daromad|AKTX - Sof moliyaviy natija|Kompaniyaning sof foydasi Enlivex Therapeutics Ltd|QTTB: Yakuniy foyda|Sof foyda GOVX|Sof foyda Edesa Biotech Inc (EDSA)|Kompaniyaning sof foydasi iBio Corp IBIO|CARM (Carisma Therapeutics Inc) - Soliqdan keyingi foyda|XTLB: Sof daromad|Bolt Biotherapeutics - Soliqlar to‘langandan keyingi foyda|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda APVO (Aptevo Therapeutics Inc.)|AIM (AIM ImmunoTech) - Sof foyda|ADTX: Yakuniy foyda|Sof foyda GRI|Sof foyda xortx.com (XRTX)|Kompaniyaning sof foydasi Vyome Holdings HIND|Yakuniy foyda REVB|INDP - Kompaniyaning sof foydasi|BiondVax Pharmaceuticals (SCNI) - Sof daromad|CALI: Sof foyda|Affimed N.V. (AFMD) - Sof foyda|Sof daromad ALLK|HOOK: Yakuniy foyda|Sof foyda IGMS|Sof moliyaviy natija iTeos Pharma|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|TCBP - Sof daromad|THRD - Kompaniyaning sof foydasi